Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT).

Autor:	Carlile O; London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Briggs A; London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Henderson AD; London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Butler-Cole BFC; Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK., Tazare J; London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Tomlinson LA; London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Marks M; London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.; Hospital for Tropical Diseases, University College London Hospital, London, WC1E 6JD, UK.; Division of Infection and Immunity, University College London, London, WC1E 6BT, UK., Jit M; London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Lin LY; London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Bates C; TPP, TPP House, 129 Low Lane, Horsforth, Leeds, LS18 5PX, UK., Parry J; TPP, TPP House, 129 Low Lane, Horsforth, Leeds, LS18 5PX, UK., Bacon SCJ; Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK., Dillingham I; Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK., Dennison WA; Patient and Public Involvement Steering Committee, London, UK., Costello RE; London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Walker AJ; Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK., Hulme W; Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK., Goldacre B; Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK., Mehrkar A; Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK., MacKenna B; Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK., Herrett E; London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Eggo RM; London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Jazyk:	angličtina
Zdroj:	The Lancet regional health. Europe [Lancet Reg Health Eur] 2024 Apr 24; Vol. 40, pp. 100908. Date of Electronic Publication: 2024 Apr 24 (Print Publication: 2024).
DOI:	10.1016/j.lanepe.2024.100908
Abstrakt:	Background: Long COVID is a major problem affecting patient health, the health service, and the workforce. To optimise the design of future interventions against COVID-19, and to better plan and allocate health resources, it is critical to quantify the health and economic burden of this novel condition. We aimed to evaluate and estimate the differences in health impacts of long COVID across sociodemographic categories and quantify this in Quality-Adjusted Life-Years (QALYs), widely used measures across health systems. Methods: With the approval of NHS England, we utilised OpenPROMPT, a UK cohort study measuring the impact of long COVID on health-related quality-of-life (HRQoL). OpenPROMPT invited responses to Patient Reported Outcome Measures (PROMs) using a smartphone application and recruited between November 2022 and October 2023. We used the validated EuroQol EQ-5D questionnaire with the UK Value Set to develop disutility scores (1-utility) for respondents with and without Long COVID using linear mixed models, and we calculated subsequent Quality-Adjusted Life-Months (QALMs) for long COVID. Findings: The total OpenPROMPT cohort consisted of 7575 individuals who consented to data collection, with which we used data from 6070 participants who completed a baseline research questionnaire where 24.6% self-reported long COVID. In multivariable regressions, long COVID had a consistent impact on HRQoL, showing a higher likelihood or odds of reporting loss in quality-of-life (Odds Ratio (OR): 4.7, 95% CI: 3.72-5.93) compared with people who did not report long COVID. Reporting a disability was the largest predictor of losses of HRQoL (OR: 17.7, 95% CI: 10.37-30.33) across survey responses. Self-reported long COVID was associated with an 0.37 QALM loss. Interpretation: We found substantial impacts on quality-of-life due to long COVID, representing a major burden on patients and the health service. We highlight the need for continued support and research for long COVID, as HRQoL scores compared unfavourably to patients with conditions such as multiple sclerosis, heart failure, and renal disease. Funding: This research was supported by the National Institute for Health and Care Research (NIHR) (OpenPROMPT: COV-LT2-0073). Competing Interests: BG has received funding via the University of Oxford from a wide range of public and charitable funders: the NHS National Institute for Health Research (NIHR), NHS England, the NIHR School of Primary Care Research, the NIHR Oxford Biomedical Research Centre, the Peter Bennett Foundation, the Laura and John Arnold Foundation, the Mohn-Westlake Foundation, NIHR Applied Research Collaboration Oxford and Thames Valley, UKRI/MRC, the Wellcome Trust, the Good Thinking Foundation, Health Data Research UK, the Health Foundation, and the World Health Organisation; he also receives personal income from speaking and writing for lay audiences on the misuse of science. He led the Goldacre Review (“Better, broader, safer: using health data for research and analysis” March 2022) for Secretary Of State for Health and Social Care; I chaired the HealthTech Advisory Board for Sec of State; I was a Non-Executive Director at NHS Digital; I am on the UKHSA Data Science Advisory Board; I have sat on various other local and national committees in the public sector. BMK is also employed by NHS England working on medicines policy and clinical lead for primary care medicines data. AM is a senior clinical researcher at the University of Oxford in the Bennett Institute, which is funded by contracts and grants obtained from the Bennett Foundation, Wellcome Trust, NIHR Oxford Biomedical Research Centre, NIHR Applied Research Collaboration Oxford and Thames Valley, Mohn-Westlake Foundation, and NHS England, and has consulted for health care vendors, the last time in 2022; the companies consulted in the last 3 years have no relationship to OpenSAFELY; he has represented the RCGP in the health informatics group and the Profession Advisory Group that advises on access to GP Data for Pandemic Planning and Research (GDPPR); the latter was a paid role; and he is a former employee and interim Chief Medical Officer of NHS Digital. REC holds shares in AstraZeneca. AB has received consulting fees from AstraZeneca, Roche, Takeda, Daiichi-Sankyo, Eisai, Novartis, Idorsia and Rhythmn. LAT has received grants or contracts from MRC, Wellcome, NIHR and GSK for an epidemiological study of kidney disease (no personal payment received) and has consulted for Bayer in relation to an observational study of chronic kidney disease (no personal payment received); she has received support for attending the MHRA Expert advisory group on Women's health and is an unpaid member of 4 non-industry funded NIHR/MRC trial advisory committees. JP has acted as an expert witness for the GMC with all fees paid to the company, and is an employee of TPP who provide the SystmOne software. MJ received support from NIHR for the funding of this manuscript and has received research grants from BMGF, Gavi, RCUK, WHO, Wellcome Trust, European Commission, InnoHK, TFGH and CDC. All other authors declare no competing interests. (© 2024 The Authors. Published by Elsevier Ltd.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu